Literature DB >> 1387731

The met proto-oncogene receptor and lumen formation.

I Tsarfaty1, J H Resau, S Rulong, I Keydar, D L Faletto, G F Vande Woude.   

Abstract

The met proto-oncogene product (Met) and its ligand, hepatocyte growth factor/scatter factor (HGF/SF), have been implicated in cell mitogenic response, cell motility, and the promotion of the ordered spatial arrangement of tissue. By means of confocal laser-scanning microscopy, it was shown that Met is expressed in cells bordering lumen-like structures that resemble ducts in the human mammary cell line T47D. In human breast tissue biopsies, Met staining was intense in normal cells bordering mammary ducts but was reduced in adjacent tumor tissue. Met staining in lumen-forming organs colocalizes with staining of antibody to phosphotyrosine, which suggests that the Met receptor and its substrates may be activated in lumen structures or ducts. HGF/SF treatment of human epithelial carcinoma cell lines resulted in the formation of lumen-like structures in vitro. Reduced expression of Met could be related to the extent of tumor cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387731     DOI: 10.1126/science.1387731

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  59 in total

Review 1.  Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy?

Authors:  W M Wong; R J Playford; N A Wright
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

2.  The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.

Authors:  D Tulasne; R Paumelle; K M Weidner; B Vandenbunder; V Fafeur
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

3.  Liver damage using suicide genes. A model for oval cell activation.

Authors:  M Bustos; B Sangro; P Alzuguren; A G Gil; J Ruiz; N Beraza; C Qian; A Garcia-Pardo; J Prieto
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

4.  Secrets of tubule engineering by epithelial cells.

Authors:  Ilan Tsarfaty; Eshel Ben-Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-23       Impact factor: 11.205

5.  Dynamics of adherence junctions during early stages of epithelial-mesenchymal transition: possible mechanisms of tube and alveolus formation in ontogeny.

Authors:  S N Rubtsova; Yu M Vasiliev
Journal:  Dokl Biol Sci       Date:  2010 Jan-Feb

6.  Activating mutations for the met tyrosine kinase receptor in human cancer.

Authors:  M Jeffers; L Schmidt; N Nakaigawa; C P Webb; G Weirich; T Kishida; B Zbar; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

7.  Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice.

Authors:  K Kawaida; K Matsumoto; H Shimazu; T Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.

Authors:  A Nusrat; C A Parkos; A E Bacarra; P J Godowski; C Delp-Archer; E M Rosen; J L Madara
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.

Authors:  F M Kong; M S Anscher; T Murase; B D Abbott; J D Iglehart; R L Jirtle
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

10.  HGF and MET mutations in primary and secondary lymphedema.

Authors:  David N Finegold; Vivien Schacht; Mark A Kimak; Elizabeth C Lawrence; Etelka Foeldi; Jenny M Karlsson; Catherine J Baty; Robert E Ferrell
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.